Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 76
Filtrar
1.
J Endocrinol Invest ; 43(4): 515-528, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31691259

RESUMEN

PURPOSE: The present study was aimed to demonstrate the recuperative effect of nesfatin-1 on testicular dysfunction in the high-fat diet (HFD)/streptozotocin (STZ)-induced type-2 diabetes mellitus (T2DM) mice. METHOD AND RESULTS: Three experimental groups were formed: (1) vehicle control (VC), (2) T2DM mice, (3) T2DM + nesf-1. The mice with blood glucose level higher than 300 mg/dL following HFD and a single dose of STZ were used for the experiment. The T2DM mice showed increases in body mass, blood glucose and insulin levels, reductions in spermatogenesis and steroidogenesis, production of antioxidative enzymes, and disturbed lipid profile. These alterations were all ameliorated by administration of nesfatin-1 at 20 µg/Kg BW for 15 days. Nesfatin-1 treatment also increased the production of testosterone (T), improved insulin sensitivity, and effectively ameliorated the testicular aberrations, and increased spermatogenesis and steroidogenesis. In addition, nesfatin-1 treatment upregulated the PCNA and Bcl2 expression and inhibited the caspase-3 and prohibitin expression in T2DM mice. Nesfatin-1 increased insulin receptor (IR) and GLUT8 expressions, and lactate production, the changes that further substantiate the increase of energy influx to the testis. CONCLUSION: Altogether, the results suggest the ameliorative effect of nesfatin-1 against T2DM-associated testicular dysfunctions and improved insulin sensitivity along with promoting T production and fertility in T2DM mice.


Asunto(s)
Diabetes Mellitus Experimental/fisiopatología , Diabetes Mellitus Tipo 2/fisiopatología , Nucleobindinas/farmacología , Reproducción/efectos de los fármacos , Espermatogénesis/efectos de los fármacos , Testículo/efectos de los fármacos , Animales , Glucemia , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Insulina/sangre , Resistencia a la Insulina , Masculino , Ratones , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Receptor de Insulina/genética , Receptor de Insulina/metabolismo , Regulación hacia Arriba/efectos de los fármacos
2.
Neuropeptides ; 68: 49-56, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29525472

RESUMEN

Hyperphagia triggers and accelerates diabetes, and prevents proper dietary control of glycemia. Inversely, the impact of hyperglycemia on hyperphagia and possible mechanistic cause common for these two metabolic disorders in type 2 diabetes are less defined. The present study examined the precise developmental process of hyperglycemia and hyperphagia and explored the alterations in the hypothalamic arcuate nucleus (ARC), the primary feeding and metabolic center, in Goto-Kakizaki (GK) rats with type 2 diabetes and nearly normal body weight. At mid 3 to 4 weeks of age, GK rats first exhibited hyperglycemia, and then hyperphagia and reduced mRNA expressions for anorexigenic pro-opiomelanocortin (POMC) and glucokinase in ARC. Furthermore, [Ca2+]i responses to high glucose in ARC POMC neurons were impaired in GK rats at 4 weeks. Treating GK rats from early 3 to mid 6 weeks of age with an anti-diabetic medicine miglitol not only suppressed hyperglycemia but ameliorated hyperphagia and restored POMC mRNA expression in ARC. These results suggest that the early hyperglycemia occurring in weaning period may lead to impaired glucose sensing and neuronal activity of POMC neurons, and thereby induce hyperphagia in GK rats. Correction of hyperglycemia in the early period may prevent and/or ameliorate the progression of hyperphagia in type 2 diabetes.


Asunto(s)
Núcleo Arqueado del Hipotálamo/metabolismo , Diabetes Mellitus Tipo 2/complicaciones , Glucosa/metabolismo , Hiperglucemia/metabolismo , Hiperfagia/metabolismo , Neuronas/metabolismo , Proopiomelanocortina/metabolismo , Animales , Glucemia , Ingestión de Alimentos , Hiperglucemia/complicaciones , Hiperfagia/etiología , Masculino , Ratas Wistar , Destete
3.
Int J Obes (Lond) ; 40(3): 425-33, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26435324

RESUMEN

BACKGROUND: Obesity and metabolic syndrome are the major risk factors for cardiovascular disease. Obesity is caused by increased food intake and/or decreased energy expenditure. Leptin potently inhibits food intake and promotes energy expenditure. These effects of leptin involve the activation of proopiomelanocortin (POMC) neurons in the hypothalamus arcuate nucleus (ARC). Disruption of leptin signaling in POMC neuron is considered one of the major causes for obesity. AIMS: The present study aimed to examine whether overexpression of interleukin-10 (IL-10) could substitute for the leptin action and ameliorate obesity in leptin-deficient Lep(ob/ob) mice. DESIGN: Adeno-associated virus (AAV) expressing murine IL-10 (AAV-mIL-10) was injected into the skeletal muscle to overexpress IL-10 in mice. These mice were subsequently subjected to analysis of body weight, food intake, glucose metabolism and underlying mechanisms. RESULTS: In Lep(ob/ob) mice, AAV-IL-10 ameliorated hyperphagia, obesity, glucose intolerance and insulin resistance, as well as attenuated tumor necrosis factor-α expression. The IL-10 treatment also improved glucose-induced insulin release. Furthermore, IL-10 treatment increased POMC mRNA expression in ARC and phosphorylation of signal transducer and activator of transcription-3 (STAT3) in ARC and white adipose tissue (WAT). In neuron-specific STAT3-null mice that exhibited obesity and hyperphagia, AAV-mIL-10 administration failed to affect food intake, body weight and phosphorylation of STAT3 in WAT. CONCLUSIONS: These results demonstrate that peripheral overexpression of IL-10 induces STAT3 phosphorylation in ARC POMC neurons, and thereby ameliorates hyperphagia and obesity caused by leptin deficiency. IL-10 gene transfer may provide an effective approach for preventing progression of metabolic syndrome due to leptin resistance.


Asunto(s)
Núcleo Arqueado del Hipotálamo/metabolismo , Diabetes Mellitus/patología , Hiperfagia/patología , Interleucina-10/metabolismo , Obesidad/patología , Proopiomelanocortina/metabolismo , Animales , Modelos Animales de Enfermedad , Metabolismo Energético , Técnicas de Transferencia de Gen , Leptina , Masculino , Ratones , Regulación hacia Arriba
4.
J Fish Biol ; 85(4): 1263-78, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25263192

RESUMEN

To clarify the regulation of expression of corticoid receptor (CR) genes during period of parr-smolt transformation of salmonids, seasonal changes in mRNA levels of glucocorticoid receptor (GR)-1, GR-2 and mineralocorticoid receptor (MR) were examined in gill, leucocytes, spleen and brain of anadromous and non-anadromous forms of Oncorhynchus mykiss. Increases in gill Na(+) , K(+) ATPase activity, plasma thyroxine levels and hypo-osmoregulatory ability assessed by 24 h seawater challenge test represented characteristics of smoltification in anadromous O. mykiss from May to June, whereas there was no apparent increase in the values of non-anadromous O. mykiss. Plasma cortisol levels of anadromous O. mykiss were higher than levels of non-anadromous O. mykiss from April to June. In gill of non-anadromous O. mykiss, there were significant increases in mRNA levels of three types of CR in spring. Although there were significant seasonal variations of CR mRNA levels in gill of anadromous O. mykiss, they appear to be less clear than those variations in non-anadromous O. mykiss. In anadromous O. mykiss, significant elevations in mRNA levels of the three types of CR were observed especially in the spleen. In both preoptic area and basal hypothalamus of the brain, there were tendencies to increase in CR mRNA levels from spring to summer in both anadromous and non-anadromous O. mykiss. These results showed difference in regulation of CR gene expression between the two forms of O. mykiss for osmoregulatory, immune and central nervous systems.


Asunto(s)
Oncorhynchus mykiss/genética , Receptores de Glucocorticoides/genética , Receptores de Mineralocorticoides/genética , Estaciones del Año , Animales , Proteínas de Peces/genética , Branquias/enzimología , Hidrocortisona/sangre , Hipotálamo/metabolismo , Oncorhynchus mykiss/fisiología , Osmorregulación , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Bazo/metabolismo , Tiroxina/sangre
5.
Endoscopy ; 44(4): 425-8, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22318340

RESUMEN

Endoscopic diagnosis of amebic colitis can be difficult because its appearance may mimic other forms of colonic disease. The aim of this study was to identify predictive endoscopic findings for amebic colitis. Patients with suspected amebic colitis based on distinctive endoscopic findings such as aphthae or erosions, ulcers, exudates, or a bump, were included in the study. A total of 157 patients were selected, 50 of whom had amebic colitis. The sensitivity and specificity of endoscopic findings that were significantly associated with amebic colitis were: cecal lesions (80% and 54%), multiple number of lesions (96% and 29%), presence of aphthae or erosions (84% and 37%), and presence of exudate (88% and 74%). Multivariate analysis revealed that the best combination of findings to predict amebic colitis was the presence of cecal lesions, multiple lesions, and exudates, which corresponded to an area under the receiver operating characteristic curve of 0.89 (95% confidence interval 0.82-0.95).


Asunto(s)
Colonoscopía , Disentería Amebiana/diagnóstico , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Enfermedades Intestinales/diagnóstico , Masculino , Persona de Mediana Edad , Análisis Multivariante , Variaciones Dependientes del Observador , Valor Predictivo de las Pruebas
6.
J Comp Physiol B ; 182(1): 77-90, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21735221

RESUMEN

Maturing adult sockeye salmon Oncorhynchus nerka were intercepted while migrating in the ocean and upstream in freshwater over a combined distance of more than 1,300 km to determine physiological and endocrine changes associated with ionoregulation. Sockeye migrating through seawater and freshwater showed consistent declines in gill Na+/K+ -ATPase (NKA) activity, plasma osmolality and plasma chloride concentration. In contrast, plasma sodium concentration became elevated in seawater as fish approached the river mouth and was then restored after sockeye entered the river. Accompanying the movement from seawater to freshwater was a significant increase in mRNA for the NKA α1a subunit in the gill, with little change in the α1b subunit. Potential endocrine signals stimulating the physiological changes during migration were assessed by measuring plasma cortisol and prolactin (Prl) concentrations and quantifying mRNA extracted from the gill for glucocorticoid receptors 1 and 2 (GR1 and GR2), mineralocorticoid receptor (MR), growth hormone 1 receptor (GH1R), and prolactin receptor (PrlR). Plasma cortisol and prolactin concentrations were high in seawater suggesting a preparatory endocrine signal before freshwater entry. Generally, the mRNA expression for GR1, GR2 and MR declined during migration, most notably after fish entered freshwater. In contrast, PrlR mRNA increased throughout migration, particularly as sockeye approached the spawning grounds. A highly significant association existed between gill PrlR mRNA and gill NKA α1a mRNA. GH1R mRNA also increased significantly, but only after sockeye had migrated beyond tidal influence in the river and then again just before the fish reached the spawning grounds. These findings suggest that cortisol and prolactin stimulate ionoregulation in the gill as sockeye salmon adapt to freshwater.


Asunto(s)
Migración Animal/fisiología , Sistema Endocrino/metabolismo , Salmón/fisiología , Animales , Colombia Británica , Cloruros/sangre , Branquias/metabolismo , Branquias/fisiología , Hidrocortisona/sangre , Concentración Osmolar , Prolactina/sangre , Receptores de Glucocorticoides/genética , Receptores de Mineralocorticoides/genética , Receptores de Prolactina/genética , Receptores de Somatotropina/genética , Ríos , Sodio/sangre , ATPasa Intercambiadora de Sodio-Potasio/genética , ATPasa Intercambiadora de Sodio-Potasio/metabolismo
7.
Transl Psychiatry ; 1: e23, 2011 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-22832525

RESUMEN

Cancer anorexia-cachexia syndrome is characterized by decreased food intake, weight loss, muscle tissue wasting and psychological distress, and this syndrome is a major source of increased morbidity and mortality in cancer patients. This study aimed to clarify the gut-brain peptides involved in the pathogenesis of the syndrome and determine effective treatment for cancer anorexia-cachexia. We show that both ghrelin insufficiency and resistance were observed in tumor-bearing rats. Corticotropin-releasing factor (CRF) decreased the plasma level of acyl ghrelin, and its receptor antagonist, α-helical CRF, increased food intake of these rats. The serotonin 2c receptor (5-HT2cR) antagonist SB242084 decreased hypothalamic CRF level and improved anorexia, gastrointestinal (GI) dysmotility and body weight loss. The ghrelin receptor antagonist (D-Lys3)-GHRP-6 worsened anorexia and hastened death in tumor-bearing rats. Ghrelin attenuated anorexia-cachexia in the short term, but failed to prolong survival, as did SB242084 administration. In addition, the herbal medicine rikkunshito improved anorexia, GI dysmotility, muscle wasting, and anxiety-related behavior and prolonged survival in animals and patients with cancer. The appetite-stimulating effect of rikkunshito was blocked by (D-Lys3)-GHRP-6. Active components of rikkunshito, hesperidin and atractylodin, potentiated ghrelin secretion and receptor signaling, respectively, and atractylodin prolonged survival in tumor-bearing rats. Our study demonstrates that the integrated mechanism underlying cancer anorexia-cachexia involves lowered ghrelin signaling due to excessive hypothalamic interactions of 5-HT with CRF through the 5-HT2cR. Potentiation of ghrelin receptor signaling may be an attractive treatment for anorexia, muscle wasting and prolong survival in patients with cancer anorexia-cachexia.


Asunto(s)
Anorexia/etiología , Caquexia/etiología , Carcinoma Hepatocelular/tratamiento farmacológico , Medicamentos Herbarios Chinos/farmacología , Ghrelina/antagonistas & inhibidores , Ghrelina/fisiología , Neoplasias Hepáticas/tratamiento farmacológico , Transducción de Señal/efectos de los fármacos , Animales , Anorexia/tratamiento farmacológico , Anorexia/mortalidad , Caquexia/tratamiento farmacológico , Caquexia/mortalidad , Carcinoma Hepatocelular/etiología , Carcinoma Hepatocelular/mortalidad , Hormona Liberadora de Corticotropina/farmacología , Hormona Liberadora de Corticotropina/fisiología , Modelos Animales de Enfermedad , Sinergismo Farmacológico , Medicamentos Herbarios Chinos/administración & dosificación , Ghrelina/deficiencia , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Hipotálamo/fisiología , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/mortalidad , Masculino , Ratas , Ratas Wistar , Receptor de Serotonina 5-HT2C/fisiología , Receptores de Ghrelina/antagonistas & inhibidores , Receptores de Ghrelina/fisiología , Estudios Retrospectivos , Transducción de Señal/genética , Análisis de Supervivencia
8.
Transplant Proc ; 41(1): 343-5, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19249552

RESUMEN

INTRODUCTION: Pituitary adenylate cyclase-activating polypeptide (PACAP) is an islet substance serving as an intra-islet amplifier of glucose-induced insulin secretion similar to exendin-4. It has been reported that systemic administration of PACAP maintained beta-cell mass, delayed the onset of hyperglycemia, and protected beta cells from glucose toxicity. Moreover, PACAP increases glucose-stimulated insulin release in vitro and in vivo. In this study, we investigated the possibility of PACAP use in human islet transplantation. METHODS: Human islets were cultured in the presence or absence of PACAP (10(-12) mol/L) for 48 hours. We assessed beta-cell viability using FACS, cellular composition analysis by iCys/LSC, and glucose-stimulated insulin secretion. In vivo, islets were transplanted beneath the kidney capsule of Streptozotocin-induced diabetic immunodeficient mice. An intravenous glucose tolerance test (IVGTT) was also performed in the presence or absence of PACAP (Peptide International, Louisville, Ky, United States; 1.3 nmol/kg). RESULTS: There were significant improvements in terms of beta-cell viability and cellular composition between islets cultured with or without PACAP, respectively (P < .05). Moreover, glucose-stimulated insulin secretion significantly improved in islets cultured with PACAP compared with controls, respectively (P < .05). Treatment of recipient mice with PACAP resulted in beneficial effects on insulin secretion (PACAP vs control, 13.2 vs 1.9 mU/L), in IVGTT. However, no significant difference was observed in glucose levels between the 2 groups. CONCLUSIONS: Our study indicated that PACAP significantly improved beta-cell viability and survival during culture, and increased insulin secretion in vitro and in vivo. However, blood glucose levels in vivo after an IVGTT did not significantly improve, probably due to increased glucagon secretion from alpha cells. PACAP supplementation to culture medium could be of assistance to improve clinical islet transplantation outcomes.


Asunto(s)
Supervivencia Celular/efectos de los fármacos , Células Secretoras de Insulina/citología , Islotes Pancreáticos/efectos de los fármacos , Islotes Pancreáticos/metabolismo , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/farmacología , Técnicas de Cultivo de Célula , Glucosa/farmacología , Humanos , Insulina/metabolismo , Secreción de Insulina , Células Secretoras de Insulina/efectos de los fármacos , Islotes Pancreáticos/citología , Trasplante de Islotes Pancreáticos/fisiología
9.
Endocrinology ; 150(2): 662-71, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19176321

RESUMEN

Nesfatin-1 is a novel satiety molecule in the hypothalamus and is also present in peripheral tissues. Here we sought to identify the active segment of nesfatin-1 and to determine the mechanisms of its action after peripheral administration in mice. Intraperitoneal injection of nesfatin-1 suppressed food intake in a dose-dependent manner. Nesfatin-1 has three distinct segments; we tested the effect of each segment on food intake. Injection of the midsegment decreased food intake under leptin-resistant conditions such as db/db mice and mice fed a high-fat diet. After injection of the midsegment, expression of c-Fos was significantly activated in the brainstem nucleus tractus solitarius (NTS) but not in the hypothalamic arcuate nucleus; the nicotinic cholinergic pathway to the NTS contributed to midsegment-induced anorexia. Midsegment injection significantly increased expression of proopiomelanocortin and cocaine- and amphetamine-regulated transcript genes in the NTS but not in the arcuate nucleus. Investigation of mutant midsegments demonstrated that a region with amino acid sequence similarity to the active site of agouti-related peptide was indispensable for anorexigenic induction. Our findings indicate that the midsegment of nesfatin-1 causes anorexia, possibly by activating POMC and CART neurons in the NTS via a leptin-independent mechanism after peripheral stimulation.


Asunto(s)
Ingestión de Alimentos/efectos de los fármacos , Leptina/fisiología , Proteínas del Tejido Nervioso/administración & dosificación , Animales , Anorexia/inducido químicamente , Núcleo Arqueado del Hipotálamo/efectos de los fármacos , Núcleo Arqueado del Hipotálamo/metabolismo , Proteínas de Unión al Calcio , Condicionamiento Psicológico/efectos de los fármacos , Proteínas de Unión al ADN , Diabetes Mellitus Experimental/patología , Diabetes Mellitus Experimental/fisiopatología , Regulación hacia Abajo/efectos de los fármacos , Ingestión de Alimentos/fisiología , Inyecciones Intraperitoneales , Masculino , Ratones , Ratones Endogámicos ICR , Proteínas del Tejido Nervioso/química , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Nucleobindinas , Proopiomelanocortina/genética , Proopiomelanocortina/metabolismo , Estructura Terciaria de Proteína/fisiología , Proteínas Proto-Oncogénicas c-fos/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Transducción de Señal/fisiología , Núcleo Solitario/efectos de los fármacos , Núcleo Solitario/metabolismo , Gusto/efectos de los fármacos
10.
J Neuroendocrinol ; 18(10): 748-56, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16965293

RESUMEN

The present study aimed to examine whether hyperphagia, which is frequently observed in type 1 diabetic patients and model animals, also occurs in type 2 diabetic Goto-Kakizaki (GK) rats and, if so, to explore underlying abnormalities in the hypothalamus. GK rats at postnatal weeks 6-12, compared to control Wistar rats, exhibited hyperphagia, hyperglycaemia, hyperleptinemia and increased visceral fat accumulation, whereas body weight was unaltered. The ability of leptin to suppress feeding was reduced in GK rats compared to Wistar rats of these ages. In GK rats, leptin-induced phosphorylation of signal transducer and activator of transcription 3 was significantly reduced in the cells of the hypothalamic arcuate nucleus (ARC), but not of the ventromedial hypothalamus, whereas the mRNA level of functional leptin receptor was unaltered. By real-time polymerase chain reaction and in situ hybridisation, mRNA levels of neuropeptide Y, but not pro-opiomelanocortin and galanin-like peptide, were significantly increased in the ARC of GK rats at 11 weeks, but not 26 weeks. Following i.c.v. injection of a NPY Y1 antagonist, 1229U91, the amount of food intake in GK rats was indistinguishable from that in Wistar rats, thus eliminating the hyperphagia of GK rats. These results demonstrate that young adult GK rats display hyperphagia in association with leptin resistance and increased NPY mRNA level in the ARC.


Asunto(s)
Núcleo Arqueado del Hipotálamo/metabolismo , Diabetes Mellitus/fisiopatología , Diabetes Mellitus/psicología , Hiperfagia/fisiopatología , Leptina/fisiología , Neuropéptido Y/biosíntesis , ARN Mensajero/biosíntesis , Animales , Núcleo Arqueado del Hipotálamo/fisiopatología , Glucemia/metabolismo , Ingestión de Alimentos/fisiología , Hiperfagia/genética , Hipotálamo/fisiopatología , Inmunohistoquímica , Hibridación in Situ , Inyecciones Intraventriculares , Neuropéptido Y/antagonistas & inhibidores , Péptidos Cíclicos/farmacología , ARN Mensajero/análisis , ARN Mensajero/genética , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Transcripción STAT3/metabolismo
11.
J Endocrinol ; 189(1): 57-65, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16614381

RESUMEN

To clarify the role of ghrelin in the fish immune system, the in vitro effect of ghrelin was examined in phagocytic leukocytes of rainbow trout (Oncorhynchus mykiss). Administration of trout ghrelin and des-VRQ-trout ghrelin, in which three amino acids are deleted from trout ghrelin, increased superoxide production in zymosan-stimulated phagocytic leukocytes from the head kidney. Gene expression of growth hormone (GH) secretagogue-receptor (GHS-R) was detected by RT-PCR in leukocytes. Pretreatment of phagocytic leukocytes with a GHS-R antagonist, [D-Lys3]-GHRP-6, abolished the stimulatory effects of trout ghrelin and des-VRQ-trout ghrelin on superoxide production. Ghrelin increased mRNA levels of superoxide dismutase and GH expressed in trout phagocytic leukocytes. Immunoneutralization of GH by addition of anti-salmon GH serum to the medium blocked the stimulatory effect of ghrelin on superoxide production. These results suggest that ghrelin stimulates phagocytosis in fish leukocytes through a GHS-R-dependent pathway, and also that the effect of ghrelin is mediated, at least in part, by GH secreted by leukocytes.


Asunto(s)
Leucocitos/efectos de los fármacos , Oncorhynchus mykiss/fisiología , Hormonas Peptídicas/farmacología , Fagocitosis/efectos de los fármacos , Superóxidos/metabolismo , Animales , Células Cultivadas , Relación Dosis-Respuesta a Droga , Expresión Génica/genética , Ghrelina , Hormona del Crecimiento/genética , Hormona del Crecimiento/metabolismo , Leucocitos/metabolismo , Oligopéptidos/farmacología , Oncorhynchus mykiss/genética , Oncorhynchus mykiss/metabolismo , ARN Mensajero/análisis , Receptores Acoplados a Proteínas G/análisis , Receptores Acoplados a Proteínas G/antagonistas & inhibidores , Receptores de Ghrelina , Superóxido Dismutasa/análisis , Zimosan/farmacología
12.
J Endocrinol ; 172(2): 345-54, 2002 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11834452

RESUMEN

When isolated rat pancreatic islets are treated with 16.7 mM glucose, a time-dependent potentiation (TDP) of insulin release occurs that can be detected by subsequent treatment with 50 mM KCl. It has been thought that TDP by glucose is a Ca2+-dependent phenomenon and only occurs when exposure to glucose is carried out in the presence of Ca2+. In contrast to this, we now demonstrate TDP under stringent Ca2+-free conditions (Ca2+-free buffer containing 1 mM EGTA). In fact, under these Ca2+-free conditions glucose caused an even stronger TDP than in the presence of Ca2+. TDP induced by glucose in the absence of extracellular Ca2+ was unaffected by inhibitors of protein kinase C (PKC). However, cerulenin or tunicamycin, two inhibitors of protein acylation, eradicated TDP without affecting glucose metabolism. The TDP by glucose was not associated with an increase in the cytosolic free Ca2+ concentration ([Ca2+]i) during subsequent treatment with high K+. Exposure of islets to forskolin under Ca(2+)-free conditions did not cause TDP despite a large increase in the cellular cAMP levels. In conclusion, glucose alone induces TDP under stringent Ca2+-free conditions when [Ca2+]i was significantly lowered. Protein acylation is implicated in the underlying mechanism of TDP.


Asunto(s)
Glucosa/farmacología , Insulina/metabolismo , Islotes Pancreáticos/metabolismo , Acilación/efectos de los fármacos , Análisis de Varianza , Animales , Calcio/metabolismo , Calcio/farmacología , Células Cultivadas , Cerulenina/farmacología , Colforsina/farmacología , AMP Cíclico/metabolismo , Inhibidores Enzimáticos/farmacología , Indoles/farmacología , Secreción de Insulina , Islotes Pancreáticos/efectos de los fármacos , Masculino , Maleimidas/farmacología , Naftalenos/farmacología , Cloruro de Potasio/farmacología , Proteína Quinasa C/antagonistas & inhibidores , Ratas , Ratas Wistar , Estadísticas no Paramétricas , Estimulación Química , Acetato de Tetradecanoilforbol/farmacología , Factores de Tiempo , Tunicamicina/farmacología
13.
Endocr J ; 48(3): 337-44, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11523905

RESUMEN

To study the effects of hydroxyl radicals on the sensitivity of the ATP-sensitive K+ (K+ ATP) channel to tolbutamide, we used patch clamp and microfluorometric techniques in pancreatic beta-cells isolated from rats. cell-attached membrane patches, exposure of the cells to 0.3 mM H2O2 increased the probability of opening of K+ATP channels in the presence of 2.8 mM glucose. Tolbutamide dose-dependently inhibited the K+ATP channel with half-maximal inhibition (IC50) at 0.8 microM before and immediately after exposure to H2O2. After prolonged exposure (>20 min) to H2O2, the IC50 was increased to 15 microM. The presence of both ATP and ADP at concentrations ranging from 0.01 to 0.1 mM in the inside-out bath solution significantly enhanced the inhibition of the channels by 10 microM tolbutamide. Addition of 0.3 mM H2O2 induced a transient minute increase in the cytoplasmic Ca2+ concentration ([Ca2+]i) within 10 min, followed by a sustained pronounced increase in [Ca2]i. After more than 20 min of exposure of cells to 0.3mM H2O2, [Ca2]i was increased to above 2 microM. Treatment of the cytoplasmic face of inside-out membrane patches with 1 microM Ca2+ attenuated the tolbutamide-sensitivity of the K+ATP channel, but not the ATP-sensitivity of the channel. These findings indicate that H2O2 reduces tolbutamide sensitivity by inducing a sustained increase in [Ca2+]i.


Asunto(s)
Adenosina Trifosfato/farmacología , Hipoglucemiantes/farmacología , Islotes Pancreáticos/fisiología , Canales de Potasio/efectos de los fármacos , Tolbutamida/farmacología , Adenosina Difosfato/farmacología , Animales , Tolerancia a Medicamentos , Conductividad Eléctrica , Radicales Libres , Peróxido de Hidrógeno/administración & dosificación , Peróxido de Hidrógeno/farmacología , Hipoglucemiantes/administración & dosificación , Técnicas de Placa-Clamp , Canales de Potasio/fisiología , Ratas , Ratas Wistar , Tolbutamida/administración & dosificación
14.
Peptides ; 22(7): 1111-7, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11445242

RESUMEN

Several studies have reported that the PAC(1) receptor (PAC1-R), the specific receptor for PACAP, is expressed at early developmental stages. Here, we describe that the cytosolic Ca(2+) concentration ([Ca(2+)](i)) was increased by PACAP, but not VIP, in a concentration range from 10(-12) to 10(-8) M via the PAC(1)-R in isolated single cells from the rat neural fold. This activation of the cells by PACAP was mimicked by agonists and inhibited by antagonists of the cAMP/PKA and PLC/PKC cascades. These data indicate that PACAP/PAC(1)-R is linked to [Ca(2+)](i) signaling via two G-protein-coupled protein kinase pathways and may thereby play an important role in early neurodevelopment.


Asunto(s)
Calcio/metabolismo , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Células Epiteliales/citología , Neuronas/citología , Neuropéptidos/farmacología , Proteína Quinasa C/metabolismo , Transducción de Señal , Animales , AMP Cíclico/metabolismo , Citosol/metabolismo , Relación Dosis-Respuesta a Droga , Activación Enzimática , Ligandos , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa , Ratas , Ratas Sprague-Dawley , Factores de Tiempo
15.
Gen Comp Endocrinol ; 122(3): 270-86, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11356039

RESUMEN

Prolactin (PRL) is an important hormone for freshwater adaptation in many teleost species. In some euryhaline fishes, growth hormone (GH) and cortisol are involved in seawater adaptation by stimulating ion extrusion. When channel catfish (Ictalurus punctatus) were transferred from fresh water to dilute seawater (300-400 mOsm), their plasma osmolality was always higher than the environmental salinity. In correlation with the increase in plasma osmolality, significant increases in plasma cortisol were observed. However, no effect of ovine GH or cortisol was seen in plasma osmolality or gill Na, K-ATPase activity when the hormones were given during the course of acclimation to dilute seawater. When catfish in fresh water were hypophysectomized, plasma osmolality was significantly decreased by 24 h, reaching a minimum level after 2 days. When they were transferred to dilute seawater, the plasma osmolality of the sham-operated fish was consistently higher than that of environmental water, whereas the osmolality of the hypophysectomized fish was equivalent to the environmental salinity. Ovine PRL restored the plasma osmolality of the hypophysectomized fish in fresh water to the level of sham-operated fish. Cortisol was also effective, but the effect was less pronounced than the effect of PRL. Injection of PRL in combination with cortisol resulted in a marked additive increase in plasma osmolality to a level even above that of the sham-operated fish. Ovine GH was without effect. These treatments in hypophysectomized fish transferred to dilute seawater produced essentially the same results as those in fish in fresh water. Plasma osmolality was also increased after PRL treatment of the intact fish in fresh water. There was a synergistic effect between PRL and cortisol in hypophysectomized fish in dilute seawater as well as in intact fish in fresh water. PRL did not stimulate cortisol secretion either in hypophysectomized fish or in intact fish. In the stenohaline catfish, both PRL and cortisol seem to be involved importantly in ion uptake from the environment not only in fresh water but also in brackish water.


Asunto(s)
Hormona del Crecimiento/fisiología , Hidrocortisona/fisiología , Ictaluridae/fisiología , Prolactina/fisiología , Equilibrio Hidroelectrolítico/fisiología , Animales , Ingestión de Líquidos/fisiología , Agua Dulce , Branquias/enzimología , Hormona del Crecimiento/farmacología , Hidrocortisona/farmacología , Hipofisectomía/veterinaria , Concentración Osmolar , Prolactina/farmacología , Distribución Aleatoria , Agua de Mar , Ovinos , ATPasa Intercambiadora de Sodio-Potasio/análisis , Tilapia/fisiología , Equilibrio Hidroelectrolítico/efectos de los fármacos
16.
Cytokine ; 13(1): 18-24, 2001 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-11145838

RESUMEN

The full-length bovine interferon-gamma (bIFN-gamma) cDNA, including the secretion signal peptide coding region was recloned into baculovirus transfer vectors pAcYM1 and pBm050. These vectors were co-transfected with Autographa californica nuclear polyhedrosis virus (AcNPV) or Bombyx mori nuclear polyhedrosis virus (BmNPV) DNA into Spodoptera frugiperda cells (SF21AE) and Bombyx mori cells (BmN), respectively. The recombinant viruses, named AcBIFN-gamma and BmBIFN-gamma, were then recovered. Recombinant bIFN-gamma (rbIFN-gamma) was accumulated in the culture fluid of AcBIFN-gamma-infected Trichoplusia ni cells and BmBIFN-gamma-infected silkworm larvae. These rbIFN-gamma forms were shown to be glycosylated 20 and 22 kDa proteins as confirmed by SDS-PAGE and tunicamycin treatment. These products were sensitive to cystein proteinase. Both rbIFN-gamma proteins, showed high-level biological activities by plaque reduction assay using vesicular stomatitis virus, and MHC class II antigen induction on bovine macrophage cells.


Asunto(s)
Interferón gamma/biosíntesis , Interferón gamma/genética , Animales , Secuencia de Bases , Bombyx , Bovinos , Línea Celular , ADN Complementario/genética , ADN Recombinante/genética , Expresión Génica , Vectores Genéticos , Glicosilación , Interferón gamma/química , Larva , Peso Molecular , Nucleopoliedrovirus/genética , Inhibidores de Proteasas/farmacología , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Spodoptera
17.
J Pharmacol Exp Ther ; 296(1): 22-30, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11123358

RESUMEN

A new nonsulfonylurea oral hypoglycemic agent, JTT-608, has been reported to stimulate insulin release at elevated, but not low, glucose concentrations and consequently not to induce hypoglycemia in rats. Accordingly, this drug is potentially a safer antidiabetic agent than sulfonylureas. To explore the mechanisms underlying this glucose-dependent insulinotropism, the present study investigated the effects of JTT-608 on cytosolic free Ca(2+) concentration ([Ca(2+)](i)) and protein kinase A (PKA) activity in rat islet beta-cells by microfluorometry using, respectively, fura-2 and a fluorescence PKA substrate, DR II. In the presence of glucose at normal and elevated concentrations (5.0-16.7 mM) JTT-608 (30-1000 microM) concentration dependently increased [Ca(2+)](i) in up to 88% of single beta-cells, whereas at lower glucose concentrations (2.8 and 4.2 mM) it had little effect. The [Ca(2+)](i) responses were inhibited under Ca(2+)-free conditions and by nitrendipine, an L-type Ca(2+) channel blocker. JTT-608 rapidly activated PKA and a PKA inhibitor, H89, inhibited [Ca(2+)](i) responses to JTT-608. JTT-608 also stimulated insulin release from rat islets in a glucose- and Ca(2+)-dependent manner. The glucose-unresponsive beta-cells, which failed to respond to 8.3 mM glucose with increases in [Ca(2+)](i), were frequently recruited to [Ca(2+)](i) increases by JTT-608. JTT-608 also induced oscillations of [Ca(2+)](i). Glucagon-like peptide-1(7-36)amide (GLP-1), pituitary adenylate cyclase-activating polypeptide (PACAP), and acetylcholine (ACh) enhanced the action of JTT-608 on [Ca(2+)](i). In conclusion, JTT-608 evokes PKA-mediated Ca(2+) influx and Ca(2+) signaling in rat islet beta-cells in a glucose-regulated manner, which may account for its glucose-dependent insulinotropism. JTT-608 and neurohormones may cooperatively activate islet beta-cells under physiological conditions.


Asunto(s)
Butiratos/farmacología , Señalización del Calcio/efectos de los fármacos , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Ciclohexanos/farmacología , Glucosa/fisiología , Hipoglucemiantes/farmacología , Insulina/metabolismo , Islotes Pancreáticos/efectos de los fármacos , Neuropéptidos/farmacología , Fragmentos de Péptidos/farmacología , Acetilcolina/fisiología , Animales , Bloqueadores de los Canales de Calcio/farmacología , Separación Celular , Células Cultivadas , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Activación Enzimática , Inhibidores Enzimáticos/farmacología , Glucagón , Péptido 1 Similar al Glucagón , Péptidos Similares al Glucagón , Islotes Pancreáticos/metabolismo , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa , Ratas , Ratas Wistar
18.
Diabetes ; 49(11): 1830-9, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11078449

RESUMEN

The factors that influence functional coupling between the sulfonylurea receptor (SUR1) and Kir6.2 subunits of ATP-sensitive K+ (K+(ATP)) channels were studied in rat pancreatic beta-cells using patch clamp and microfluorometric techniques. Tolbutamide at 10 micromol/l inhibited K+(ATP) channels in association with occurrence of action currents, but further exposure of beta-cells to the drug for 30 min or longer resulted in reappearance of K+(ATP) channel events. Half-maximal inhibition concentration (IC50) for tolbutamide was 1.5 microl/mol in 2.8 mmol/l glucose, and it was increased to 13.3 micromol/l when the cellular metabolism was inhibited by 0.5 mmol/l 2,4-dinitrophenol (DNP) for 5 min. Tolbutamide at 10 micromol/l induced an increase in cytosolic Ca2+ concentration ([Ca2+]i), and its amplitude was markedly reduced following exposure to 0.5 mmol/l DNP or long-term (30 min) exposure to 10 micromol/l tolbutamide. This tolbutamide insensitivity, as assessed by the [Ca2+]i response, was not observed when the external Ca2+ was omitted during the long-term exposure to tolbutamide. In cell-attached membrane patches, the tolbutamide insensitivity was also produced by treatment of cells with 150 micromol/l diazoxide and 25 mmol/l KCl in the presence, but not absence, of 2 mmol/l Ca2+ in the external solution. When the cytoplasmic face of inside-out membrane patches was treated with higher Ca2+ concentrations (2 micromol/l), both ADP-evoked activation and tolbutamide-induced inhibition of K+ ATP channels were attenuated with retaining ATP-induced inhibition, indicating the modification of K+(ATP) channels. The Ca2+-induced channel modification was prevented partially by phosphatidylinositol 4,5-bisphosphate (PIP2) and completely by ATP and PIP2 together, but not by ATP alone. Treatment of the channel with cytochalasin D, a disrupter of F-actin, evoked channel modification similar to that induced by Ca2+. The modification was prevented completely by phalloidin, a stabilizer of F-actin. In conclusion, long-term exposure to tolbutamide or metabolic inhibition causes modification of K+ ATP channels via mechanisms involving Ca2+-dependent reaction. The modification, which may reflect functional disconnection between SUR1 and Kir6.2, is prevented by ATP and PIP2, which may act cooperatively to stabilize membrane cytoskeletons (F-actin structures).


Asunto(s)
Adenosina Trifosfato/farmacología , Calcio/farmacología , Citosol/química , Islotes Pancreáticos/metabolismo , Fosfatidilinositol 4,5-Difosfato/farmacología , Canales de Potasio/efectos de los fármacos , 2,4-Dinitrofenol/farmacología , Actinas/antagonistas & inhibidores , Actinas/fisiología , Adenosina Difosfato/farmacología , Animales , Calcio/metabolismo , Citocalasina D/farmacología , Diazóxido/farmacología , Conductividad Eléctrica , Técnicas de Placa-Clamp , Faloidina/farmacología , Canales de Potasio/fisiología , Cloruro de Potasio/farmacología , Ratas , Ratas Wistar , Tolbutamida/farmacología
19.
J Oral Maxillofac Surg ; 58(7): 767-75, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10883692

RESUMEN

PURPOSE: This study investigated the ability of chondrocytes grown in culture and inoculated into a newly developed biodegradable sponge to form ectopic cartilage tissue. MATERIALS AND METHODS: Chondrocytes obtained from costochondral cartilage dissected from Lewis rats were cultured to allow proliferation and then were inoculated into a sponge consisting of a biodegradable polymer, poly (L-lactide-epsilon-caprolactone). The composites of chondrocytes and sponge were transplanted subcutaneously into Nude mice and removed after 4 weeks for histologic and Northern blot analysis. RESULTS: Staining with hematoxylin and eosin showed the formation of a cartilage-like structure in the sponge. Northern blot analysis of the total RNA in the composites showed the presence of aggrecan transcripts of about 9 kb. CONCLUSION: The poly (L-lactide-epsilon-caprolactone) sponge system, is suitable as a matrix for tissue-engineered cartilage.


Asunto(s)
Implantes Absorbibles , Caproatos , Cartílago/crecimiento & desarrollo , Trasplante de Células , Condrocitos/trasplante , Proteínas de la Matriz Extracelular , Lactonas , Poliésteres/farmacología , Agrecanos , Animales , Biotecnología , Northern Blotting , Cartílago/metabolismo , Técnicas de Cultivo de Célula/métodos , Células Cultivadas , Condrocitos/citología , Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Inmunohistoquímica , Lectinas Tipo C , Masculino , Ratones , Ratones Desnudos , Proteoglicanos/metabolismo , Ratas , Ratas Endogámicas Lew
20.
Nature ; 405(6784): 311-9, 2000 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-10830953

RESUMEN

Chromosome 21 is the smallest human autosome. An extra copy of chromosome 21 causes Down syndrome, the most frequent genetic cause of significant mental retardation, which affects up to 1 in 700 live births. Several anonymous loci for monogenic disorders and predispositions for common complex disorders have also been mapped to this chromosome, and loss of heterozygosity has been observed in regions associated with solid tumours. Here we report the sequence and gene catalogue of the long arm of chromosome 21. We have sequenced 33,546,361 base pairs (bp) of DNA with very high accuracy, the largest contig being 25,491,867 bp. Only three small clone gaps and seven sequencing gaps remain, comprising about 100 kilobases. Thus, we achieved 99.7% coverage of 21q. We also sequenced 281,116 bp from the short arm. The structural features identified include duplications that are probably involved in chromosomal abnormalities and repeat structures in the telomeric and pericentromeric regions. Analysis of the chromosome revealed 127 known genes, 98 predicted genes and 59 pseudogenes.


Asunto(s)
Cromosomas Humanos Par 21 , Secuencia de Bases , Mapeo Cromosómico , ADN , Síndrome de Down/genética , Genes , Humanos , Datos de Secuencia Molecular , Mutación , Análisis de Secuencia de ADN
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA